SGS742: Phase II data

By WIR Staff | May 3, 2004 | 7:00 AM GMT

In an eight-week, placebo-controlled, U.S. Phase II study in 110 patients, SGS742 did not

Read the full 140 word article

How to gain access

Continue reading with a
two-week free trial.